Contact

Payer

Pharma

Provider

Formulary guidance and transparency from P&T to point of care

MMIT Reality Check on HIV (Sep 2016)

Posted by Matt Breese on Sep 24, 2016

According to our recent payer coverage analysis for HIV treatments, combined with news from key healthcare influencers, market access is shifting in this drug landscape.

To help make sense of this new research, MMIT's team of experts analyzes the data and summarizes the key findings for you. The following are brief highlights. To read the full piece, including payer coverage, drug competition and prescriber trends, click here.

Read More

Topics: Specialty, Market Access, Payer, Branding & Marketing

Trends that Matter for Pharmacist Influence

Posted by Matt Breese on Sep 22, 2016

A collection of engaging infographics from healthcare influencers that reveals trends in pharmacists' role in healthcare:

The role of the pharmacist is shifting as their relationship with the patient grows stronger. One-third of Americans take 5 or more medications, with medicare beneficiaries making up the great majority of scripts. From Parata.

Read More

Topics: Industry Trends, Provider, Branding & Marketing

Perspectives on Formulary Storytelling

Posted by Matt Breese on Sep 20, 2016

Who doesn’t like a good story? A Star Wars epic. A novel you just can’t put down. A news story about a lost puppy. Stories are just as much a marketing tool as they are fodder for the big screen, books and news media. Brands like Guinness, Dove and Nike often use storytelling to promote their brands in softer, unexpected and more memorable ways.

Read More

Topics: Industry Trends, Branding & Marketing

MMIT Reality Check on PCSK9 Inhibitors (Sep 2016)

Posted by Matt Breese on Sep 16, 2016

According to our recent payer coverage analysis for PCSK9 inhibitors, combined with news from key healthcare influencers, market access is shifting in this drug landscape.

To help make sense of this new research, MMIT's team of experts analyzes the data and summarizes the key findings for you. The following are brief highlights. To read the full piece, including payer coverage, drug competition and prescriber trends, click here.

Read More

Topics: Specialty, Market Access, Branding & Marketing

Perspectives on Sales Messaging (Pt. 2)

Posted by Matt Breese on Sep 16, 2016

Earlier this week, we discussed the criteria a pharma sales rep (PSR) should consider integrating into their sales tactics.  Today, we continue that discussion.

Read More

Topics: Industry Trends, Branding & Marketing

Perspectives on Sales Messaging (Pt. 1)

Posted by Matt Breese on Sep 13, 2016

Gone are the days when a pharma sales rep (PSR) could take a healthcare provider out to dinner and seal the deal over coffee and dessert. Today, ethical implications, regulatory oversight, practice/hospital mergers and time-crunching clinic schedules limit the amount of one-on-one face-time a PSR has with a provider.

Read More

Topics: Industry Trends, Branding & Marketing

Formulary Search 2.5 Years In

Posted by Stu Allen on Sep 12, 2016

With the Formulary Search (Android, Apple, Web) app turning 2 ½ I thought I’d take a minute to recap progress made in the tool over its relatively young lifespan as well as provide some insight into what the evolution of the tool has taught MMIT over that same time period.

Read More

Topics: Market Access, Product Release, Data & Analytics

Numbers that Matter in Patient Centricity

Posted by Matt Breese on Sep 9, 2016

A collection of engaging infographics and articles from healthcare influencers to highlight trends in patient-centered healthcare.

41% of patients take action with their own health when activation levels are high. Pharma brand marketers dedicate 10-20% of budget to patient support programsaccording to Quintiles.

Read More

Topics: Industry Trends, Provider

MMIT Reality Check on Cystic Fibrosis (September 2016)

Posted by Matt Breese on Sep 8, 2016

According to our recent payer coverage analysis for CF treatments, combined with news from key healthcare influencers, market access is shifting in this drug landscape.

To help make sense of this new research, MMIT's team of experts analyzes the data and summarizes the key findings for you. The following are brief highlights. To read the full piece, including payer coverage, drug competition and prescriber trends, click here.

Read More

Topics: Market Access, Branding & Marketing

Perspectives on PBM Consolidation (Pt. 2)

Posted by Matt Breese on Sep 6, 2016

Before the holiday, we discussed PBM consolidation and its effects in the pharma and healthcare landscape.  Today, we continue that discussion.

The Effects of Mergers

As a result of the ExpressScripts/Medco and UnitedHealth/Catamaran Rx mergers, one billion scripts — 75 percent of the U.S. total — is now controlled by three players: ExpressScripts, UnitedHealth OptumRx and CVS Caremark.

Read More

Topics: Industry Trends, Payer